Could an antidepressant tame hot flashes without hormones?
NCT ID NCT06763484
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether paroxetine, a common antidepressant, can reduce hot flashes and night sweats in women who entered menopause after surgery. 90 women took either paroxetine or a placebo daily for 6 months. The goal was to see if paroxetine could be a safer alternative to hormone therapy, which carries risks like blood clots.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Paroxetine
- What this could lead to
- If it works, this could offer a non-hormonal option to ease hot flashes and night sweats for women who cannot take hormone therapy.
- What could go wrong
- This is a small, Phase 2 trial with only 90 participants. Paroxetine may cause side effects and might not work better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
90 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with surgical menopause attending IHSS outpatient clinic. * Patients with surgical menopause with presence of hot flashes and night sweats. * Surgical menopausal patients with episodes of anxiety and palpitations. * Patients with surgical menopause who receive treatment for 6 months with Paroxetine. * Patients who after reading and explanation of the Informed Consent agree to participate voluntarily. Exclusion Criteria: * Patients medicated with psychotropic drugs, including all sedatives and hypnotics. * Patients under treatment with Menopausal Hormone Therapy. * Patients with impaired hepatic or renal function. * Patients with unstable heart disease. * Patients with a history of self-destructive behaviors. * Patients with a history of clinical diagnosis or treatment for depression or any other psychiatric disorder (including substance abuse or alcohol disorders) and any other ongoing medical condition.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hot flashes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Hondureño de Seguridad Social
Tegucigalpa, Francisco Morazán Department, 11101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Non-Hormonal pill targets hot flashes in menopause
- A cool wristband takes on hot flashes — no drugs needed
- Could a cold shower cool menopausal hot flashes?
- Hot flashes linked to heart risk? mayo clinic investigates
- Massive new registry to track menopause health in 5,000 women
- New drug fezolinetant tested for hot flash relief in everyday life